{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Normal+Pregnancy&page=29", "query": { "condition": "Normal Pregnancy", "page": 29 }, "page_size": 10 }, "pagination": { "page": 29, "page_size": 10, "total_count": 1974, "total_pages": 198, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Normal+Pregnancy&page=30&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Normal+Pregnancy&page=28&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-27T10:03:36.807Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00447265", "title": "Etanercept for the Treatment of Lupus Nephritis", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Lupus Nephritis" ], "interventions": [ { "name": "Etanercept", "type": "DRUG" }, { "name": "Lupus Treatment- Standard of Care", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 1, "start_date": "2008-02", "completion_date": "2009-03", "has_results": true, "last_update_posted_date": "2013-02-12", "last_synced_at": "2026-10-27T10:03:36.807Z", "location_count": 6, "location_summary": "Birmingham, Alabama • San Francisco, California • Aurora, Colorado + 3 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "San Francisco", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Manhasset", "state": "New York" }, { "city": "Rochester", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00447265" }, { "nct_id": "NCT05542407", "title": "ONC201 and Atezolizumab in Obesity-Driven Endometrial Cancer", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Endometrial Cancer", "Metastasis", "Endometrioid Endometrial Cancer", "Carcinosarcoma", "Serous Adenocarcinoma of Endometrium (Diagnosis)", "Clear Cell Endometrial Carcinoma", "Endometrial Endometrioid Adenocarcinoma", "Endometrial Mixed Cell Adenocarcinoma" ], "interventions": [ { "name": "Atezolizumab", "type": "DRUG" }, { "name": "ONC201", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "UNC Lineberger Comprehensive Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 58, "start_date": "2023-10-23", "completion_date": "2028-07-31", "has_results": false, "last_update_posted_date": "2026-01-29", "last_synced_at": "2026-10-27T10:03:36.807Z", "location_count": 1, "location_summary": "Chapel Hill, North Carolina", "locations": [ { "city": "Chapel Hill", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT05542407" }, { "nct_id": "NCT04260464", "title": "Renal Impairment Study of PF-06700841", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Volunteer", "Renal Impairment" ], "interventions": [ { "name": "PF-06700841", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 30, "start_date": "2020-07-03", "completion_date": "2022-05-04", "has_results": true, "last_update_posted_date": "2024-01-22", "last_synced_at": "2026-10-27T10:03:36.807Z", "location_count": 3, "location_summary": "Miami, Florida • Saint Paul, Minnesota", "locations": [ { "city": "Miami", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "Saint Paul", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT04260464" }, { "nct_id": "NCT00827177", "title": "Dose Escalation Study of ARQ 197 in Combination With Sorafenib in Adult Patients With Advanced Solid Tumors", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Advanced Solid Tumors" ], "interventions": [ { "name": "Treatment with ARQ 197 in combination with sorafenib", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 87, "start_date": "2009-09", "completion_date": "2013-05", "has_results": false, "last_update_posted_date": "2014-01-24", "last_synced_at": "2026-10-27T10:03:36.807Z", "location_count": 3, "location_summary": "Boston, Massachusetts • Buffalo, New York • Nashville, Tennessee", "locations": [ { "city": "Boston", "state": "Massachusetts" }, { "city": "Buffalo", "state": "New York" }, { "city": "Nashville", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT00827177" }, { "nct_id": "NCT01051336", "title": "Safety and Tolerability Study of the Taris Placebo System", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "TARIS Placebo", "type": "DEVICE" }, { "name": "Sham Procedure", "type": "PROCEDURE" } ], "intervention_types": [ "DEVICE", "PROCEDURE" ], "sponsor": "TARIS Biomedical, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "FEMALE", "summary": "18 Years to 55 Years · Female only" }, "enrollment_count": 10, "start_date": "2009-10", "completion_date": "2009-11", "has_results": false, "last_update_posted_date": "2010-01-18", "last_synced_at": "2026-10-27T10:03:36.807Z", "location_count": 1, "location_summary": "Phoenix, Arizona", "locations": [ { "city": "Phoenix", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT01051336" }, { "nct_id": "NCT00898365", "title": "Study of Kidney Tumors in Younger Patients", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Adult Cystic Nephroma", "Anaplastic Kidney Wilms Tumor", "Angiolipoma", "Cellular Congenital Mesoblastic Nephroma", "Classic Congenital Mesoblastic Nephroma", "Clear Cell Sarcoma of the Kidney", "Congenital Mesoblastic Nephroma", "Cystic Partially Differentiated Kidney Nephroblastoma", "Diffuse Hyperplastic Perilobar Nephroblastomatosis", "Extrarenal Rhabdoid Tumor", "Kidney Medullary Carcinoma", "Kidney Neoplasm", "Kidney Oncocytoma", "Kidney Wilms Tumor", "Metanephric Adenofibroma", "Metanephric Adenoma", "Metanephric Stromal Tumor", "Metanephric Tumor", "Mixed Congenital Mesoblastic Nephroma", "Ossifying Renal Tumor of Infancy", "Papillary Renal Cell Carcinoma", "Renal Cell Carcinoma", "Renal Cell Carcinoma Associated With Xp11.2 Translocations/TFE3 Gene Fusions", "Rhabdoid Tumor of the Kidney", "Wilms Tumor" ], "interventions": [ { "name": "Cytology Specimen Collection Procedure", "type": "OTHER" }, { "name": "Laboratory Biomarker Analysis", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Children's Oncology Group", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "29 Years", "sex": "ALL", "summary": "Up to 29 Years" }, "enrollment_count": 8000, "start_date": "2006-02-27", "completion_date": "2026-03-31", "has_results": false, "last_update_posted_date": "2026-05-18", "last_synced_at": "2026-10-27T10:03:36.807Z", "location_count": 214, "location_summary": "Birmingham, Alabama • Mobile, Alabama • Anchorage, Alaska + 153 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Anchorage", "state": "Alaska" }, { "city": "Phoenix", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT00898365" }, { "nct_id": "NCT06962774", "title": "An Investigational Study of ESK-001 in Participants With Normal Renal Function and Participants With Mild, Moderate, and Severe Impaired Renal Function", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Renal Impairment" ], "interventions": [ { "name": "ESK-001", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Alumis Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 16, "start_date": "2025-04-23", "completion_date": "2025-08-01", "has_results": false, "last_update_posted_date": "2025-12-10", "last_synced_at": "2026-10-27T10:03:36.807Z", "location_count": 4, "location_summary": "Miami, Florida • Miami Lakes, Florida • Orlando, Florida", "locations": [ { "city": "Miami", "state": "Florida" }, { "city": "Miami Lakes", "state": "Florida" }, { "city": "Miami Lakes", "state": "Florida" }, { "city": "Orlando", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT06962774" }, { "nct_id": "NCT00003308", "title": "Radiation Therapy in Treating Patients With Newly Diagnosed Brain Metastases From Kidney Cancer, Melanoma, or Sarcoma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Kidney Cancer", "Melanoma (Skin)", "Metastatic Cancer", "Ovarian Cancer", "Sarcoma" ], "interventions": [ { "name": "stereotactic radiosurgery", "type": "RADIATION" } ], "intervention_types": [ "RADIATION" ], "sponsor": "Eastern Cooperative Oncology Group", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "120 Years", "sex": "ALL", "summary": "18 Years to 120 Years" }, "enrollment_count": null, "start_date": "1999-02-02", "completion_date": null, "has_results": false, "last_update_posted_date": "2023-06-22", "last_synced_at": "2026-10-27T10:03:36.807Z", "location_count": 11, "location_summary": "Des Moines, Iowa • Kalamazoo, Michigan • Papillion, Nebraska + 5 more", "locations": [ { "city": "Des Moines", "state": "Iowa" }, { "city": "Des Moines", "state": "Iowa" }, { "city": "Des Moines", "state": "Iowa" }, { "city": "Kalamazoo", "state": "Michigan" }, { "city": "Papillion", "state": "Nebraska" } ], "official_url": "https://clinicaltrials.gov/study/NCT00003308" }, { "nct_id": "NCT02217891", "title": "IFACT: Incidental Findings in Advanced Cancer Therapy", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Breast Cancer", "Colorectal Cancer", "Bladder Cancer", "Lung Cancer" ], "interventions": [ { "name": "Semi-structured interview", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Memorial Sloan Kettering Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 60, "start_date": "2014-08", "completion_date": "2023-02-09", "has_results": false, "last_update_posted_date": "2023-02-13", "last_synced_at": "2026-10-27T10:03:36.807Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT02217891" }, { "nct_id": "NCT01666444", "title": "VTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Epithelial Ovarian Cancer", "Fallopian Tube Cancer", "Primary Peritoneal Cancer" ], "interventions": [ { "name": "pegylated liposomal doxorubicin (PLD)", "type": "DRUG" }, { "name": "VTX-2337", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Celgene", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 297, "start_date": "2012-10-31", "completion_date": "2016-07-31", "has_results": true, "last_update_posted_date": "2019-09-26", "last_synced_at": "2026-10-27T10:03:36.807Z", "location_count": 136, "location_summary": "Phoenix, Arizona • Little Rock, Arkansas • Burbank, California + 104 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Burbank", "state": "California" }, { "city": "Hayward", "state": "California" }, { "city": "Long Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01666444" } ] }